Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Usman"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leroux-Roels I; Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital, 9000 Ghent, Belgium., Maes C; Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital, 9000 Ghent, Belgium., Mancini F; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Jacobs B; Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital, 9000 Ghent, Belgium., Sarakinou E; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Alhatemi A; Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital, 9000 Ghent, Belgium., Joye J; Center for Vaccinology (CEVAC), Ghent University and Ghent University Hospital, 9000 Ghent, Belgium., Grappi S; VisMederi, 53035 Siena, Italy., Cilio GL; Vaccines Global Safety, GSK, 53100 Siena, Italy., Serry-Bangura A; Vaccines Global Safety, GSK, 53100 Siena, Italy., Vitali CG; Vaccines Toxicology Center of Excellence, GSK, 53100 Siena, Italy., Ferruzzi P; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Marchetti E; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Necchi F; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Rappuoli R; GSK Biologicals, 53100 Siena, Italy., De Ryck I; Vaccines Global Safety, GSK, 53100 Siena, Italy., Auerbach J; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Colucci AM; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Rossi O; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Conti V; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Scorza FB; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Arora AK; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Micoli F; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Podda A; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy., Nakakana UN; GSK Vaccines Institute for Global Health (GVGH), GSK, 53100 Siena, Italy.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Jun 10. Date of Electronic Publication: 2024 Jun 10.
Autor:
Voorman A; The Bill & Melinda Gates Foundation, Seattle, Washington, USA., Lyons H; The Bill & Melinda Gates Foundation, Seattle, Washington, USA., Shuaib F; National Primary Health Care Development Agency, Abuja, Nigeria., Adamu US; National Primary Health Care Development Agency, Abuja, Nigeria., Korir C; World Health Organization, Nigeria Country Office, Abuja, Nigeria., Erbeto T; World Health Organization, Nigeria Country Office, Abuja, Nigeria., Bandyopadhyay AS; The Bill & Melinda Gates Foundation, Seattle, Washington, USA., Okiror S; The Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Mar 14; Vol. 229 (3), pp. 805-812.